Swiss drugmaker Novartis AG is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co for about $7 billion, the Wall Street Journal reported on Saturday.
You are here: Home / Financial Planning / Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion – WSJ
Leave a Reply